Rejuvel Bio-Sciences (NUUU) Stock Overview

A development stage company, produces, distributes, markets, and sells skin care products worldwide. More details

NUUU fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Does not have a meaningful market cap ($9K)

Latest financial reports are more than a year old

Shares are highly illiquid

NUUU Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW437,476 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.

Grow your followingReal investors. The kind who actually invest, not scroll past.

Unlock free accessFree premium subscription for consistent and quality authors.

Learn more Create Narrative

437,476 investors already sharing narratives

View all narratives

Rejuvel Bio-Sciences, Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Rejuvel Bio-Sciences
Historical stock prices
Current Share Price	US$0.000001
52 Week High	US$0.0001
52 Week Low	US$0.000001
Beta	0
1 Month Change	0%
3 Month Change	0%
1 Year Change	n/a
3 Year Change	0%
5 Year Change	-99.00%
Change since IPO	-99.90%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	NUUU	US Personal Products	US Market
7D	0%	-5.3%	-2.2%
1Y	n/a	-7.7%	13.1%

Return vs Industry: Insufficient data to determine how NUUU performed against the US Personal Products industry.

Return vs Market: Insufficient data to determine how NUUU performed against the US Market.

Price Volatility

Is NUUU's price volatile compared to industry and market?
NUUU volatility
NUUU Average Weekly Movement	n/a
Personal Products Industry Average Movement	9.4%
Market Average Movement	6.9%
10% most volatile stocks in US Market	15.4%
10% least volatile stocks in US Market	2.9%

Stable Share Price: NUUU's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine NUUU's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2009	n/a	Charles Scimeca	www.rejuvel.com

Rejuvel Bio-Sciences, Inc., a development stage company, produces, distributes, markets, and sells skin care products worldwide. The company primarily offers skin cream under the Rejuvel brand. It also intends to develop, build, and sell environmental management solutions that use electron particle accelerator technology for the treatment of drinking water, municipal and industrial wastewater, sludge, and produced water from oil and gas fracturing activities.

Rejuvel Bio-Sciences, Inc. Fundamentals Summary

How do Rejuvel Bio-Sciences's earnings and revenue compare to its market cap?
NUUU fundamental statistics
Market cap	US$8.84k
Earnings (TTM)	-US$1.05m
Revenue (TTM)	US$187.33k

0.0x

P/S Ratio

0.0x

P/E Ratio

Is NUUU overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
NUUU income statement (TTM)
Revenue	US$187.33k
Cost of Revenue	US$98.52k
Gross Profit	US$88.81k
Other Expenses	US$1.14m
Earnings	-US$1.05m

Last Reported Earnings

Sep 30, 2015

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did NUUU perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/09/11 04:16
End of Day Share Price	2026/09/09 00:00
Earnings	2015/09/30
Annual Earnings	2014/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Rejuvel Bio-Sciences, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.